206 related articles for article (PubMed ID: 22654525)
21. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
22. Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies.
Escobar-Morreale HF; Asunción M; Calvo RM; Sancho J; San Millán JL
Eur J Endocrinol; 2001 Nov; 145(5):619-24. PubMed ID: 11720881
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of different ranges of LH:FSH ratios in polycystic ovarian syndrome (PCOS) - Clinical based case control study.
Malini NA; Roy George K
Gen Comp Endocrinol; 2018 May; 260():51-57. PubMed ID: 29273352
[TBL] [Abstract][Full Text] [Related]
24. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
25. Which hormone tests for the diagnosis of polycystic ovary syndrome?
Robinson S; Rodin DA; Deacon A; Wheeler MJ; Clayton RN
Br J Obstet Gynaecol; 1992 Mar; 99(3):232-8. PubMed ID: 1296589
[TBL] [Abstract][Full Text] [Related]
26. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
Arroyo A; Laughlin GA; Morales AJ; Yen SS
J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
[TBL] [Abstract][Full Text] [Related]
27. Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome.
Ciccone MM; Favale S; Bhuva A; Scicchitano P; Caragnano V; Lavopa C; De Pergola G; Loverro G
Vasc Health Risk Manag; 2009; 5(3):561-6. PubMed ID: 19590590
[TBL] [Abstract][Full Text] [Related]
28. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome.
Ardawi MS; Rouzi AA
Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640
[TBL] [Abstract][Full Text] [Related]
29. Serum HLA-G levels in women with polycystic ovary syndrome.
Oztekin O; Fenkci SM; Fenkci V; Enli Y; Cabus U
Gynecol Endocrinol; 2015 Mar; 31(3):243-6. PubMed ID: 25403326
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Endocrine and Metabolic Indexes in Non-Obese Patients with Polycystic Ovary Syndrome and Its Compare with Obese Patients.
Shi W; Zhao Q; Zhao X; Xing C; He B
Diabetes Metab Syndr Obes; 2021; 14():4275-4281. PubMed ID: 34703260
[TBL] [Abstract][Full Text] [Related]
31. The predictive power of endocrine tests for the diagnosis of polycystic ovaries in women with oligoamenorrhea.
Turhan NO; Toppare MF; Seçkin NC; Dilmen G
Gynecol Obstet Invest; 1999; 48(3):183-6. PubMed ID: 10545743
[TBL] [Abstract][Full Text] [Related]
32. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
33. Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome.
Evliyaoglu O; Imöhl M; Weiskirchen R; van Helden J
Clin Chem Lab Med; 2020 Jul; 58(8):1291-1301. PubMed ID: 32069226
[TBL] [Abstract][Full Text] [Related]
34. A Comparison of the Hormonal Profile of Early Androgenetic Alopecia in Men With the Phenotypic Equivalent of Polycystic Ovarian Syndrome in Women.
Sanke S; Chander R; Jain A; Garg T; Yadav P
JAMA Dermatol; 2016 Sep; 152(9):986-91. PubMed ID: 27304785
[TBL] [Abstract][Full Text] [Related]
35. Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.
Loverro G; Vicino M; Lorusso F; Vimercati A; Greco P; Selvaggi L
Gynecol Endocrinol; 2001 Apr; 15(2):142-9. PubMed ID: 11379011
[TBL] [Abstract][Full Text] [Related]
36. Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.
Patel K; Coffler MS; Dahan MH; Malcom PJ; Deutsch R; Chang RJ
Clin Endocrinol (Oxf); 2004 Jan; 60(1):67-74. PubMed ID: 14678290
[TBL] [Abstract][Full Text] [Related]
37. Focus on BMI and subclinical hypothyroidism in adolescent girls first examined for amenorrhea or oligomenorrhea. The emerging role of polycystic ovary syndrome.
Nezi M; Christopoulos P; Paltoglou G; Gryparis A; Bakoulas V; Deligeoroglou E; Creatsas G; Mastorakos G
J Pediatr Endocrinol Metab; 2016 Jun; 29(6):693-702. PubMed ID: 27089404
[TBL] [Abstract][Full Text] [Related]
38. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
39. Inappropriate gonadotropin secretion in polycystic ovary syndrome.
Hsu MI; Liou TH; Liang SJ; Su HW; Wu CH; Hsu CS
Fertil Steril; 2009 Apr; 91(4):1168-74. PubMed ID: 18325508
[TBL] [Abstract][Full Text] [Related]
40. Anti-Mullerian Hormone: an indicator for the severity of polycystic ovarian syndrome.
Köninger A; Koch L; Edimiris P; Enekwe A; Nagarajah J; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
Arch Gynecol Obstet; 2014 Nov; 290(5):1023-30. PubMed ID: 24961320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
